|
|
SBIR PHASE I: ANTIBODY ARRAY FOR CANCER DETECTION
|
N43CN700065-000
|
|
$0
|
BOCHKARIOV, DMITRY
|
ADVANSTA INC
|
|
|
Education for Healthcare Providers of Alaska Natives
|
5R25CA104120-05
|
$307,210
|
$153,605
|
Lanier, Anne
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
|
An Exploration of the Determinants that Impact Breast and Cervical Cancer Control
|
5R03CA132550-02
|
$50,000
|
$25,000
|
English, Kevin
|
ALBUQUERQUE AREA INDIAN HEALTH BOARD
|
|
|
MicroRNA biomarkers for early detection of prostate cancer
|
1R43CA135917-01
|
$215,621
|
$53,905
|
BROWN, DAVID
|
AMBION DIAGNOSTICS, INC.
|
|
|
Young Minority Scientists in the Field of Cancer
|
5R13CA040577-23
|
$214,489
|
$10,724
|
CLARKSON, BAYARD
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
2U01CA098710-05
|
$1,063,219
|
$265,805
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S2
|
$9,611,397
|
$1,249,482
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S3
|
$3,952
|
$514
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S4
|
$80,640
|
$10,483
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-21S1
|
$27,801
|
$3,614
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-21
|
$1,665,362
|
$216,497
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RTOG Tissue Bank
|
5U24CA114734-04
|
$793,026
|
$39,651
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group-Statistical Center
|
3U10CA032115-26S1
|
$1,010,519
|
$131,367
|
Sadek, Ramses
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
American College of Radiology Imaging Network
|
2U01CA080098-10
|
$9,101,961
|
$455,098
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-10
|
$740,839
|
$296,336
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Platelet-Based Nanoparticle Therapy for Prostate Cancer
|
N43CO800063-000
|
$149,994
|
$37,499
|
ZWICK, MICHAEL
|
ANDROBIOSYS, INC.:1150748
|
|
|
Investigating intervention opportunities for prostate cancer patients and partner
|
5R03CA128475-02
|
$73,701
|
$18,425
|
COON, DAVID
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Targeted Ceramic Nanovectors for Simultaneous Therapy and Imaging of Cancer
|
1R21CA133618-01
|
$231,517
|
$57,879
|
DEY, SANDWIP
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
2R01CA090441-06A2
|
$381,250
|
$19,063
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Microfluidics-Based Platform for Screening Combinatorial Drug Treatments
|
1R21CA131891-01A1
|
$210,715
|
$52,679
|
Rege, Kaushal
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
PHASE I AND II CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035158-009
|
$1,500,000
|
$150,000
|
CHOW, SHERRY
|
ARIZONA UNIV:1109859
|
|
|
Portable Imaging Device for Prostate Cancer Detection
|
5R44CA082620-06
|
$1,000,000
|
$250,000
|
Sarvazyan, Armen
|
ARTANN LABORATORIES, INC.
|
|
|
Antibody therapeutics - feasibility study on hormone-refrectory prostate cancer m
|
1R43CA137929-01
|
$185,061
|
$46,265
|
CHANG, JIA
|
ATTOGEN, INC
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$24,060
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
Role of NCoR in Antiandrogen Resistance in Prostate Cancer
|
1R21CA129265-01A1
|
$207,225
|
$51,806
|
AGOULNIK, IRINA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targeting Relaxin Signaling in Prostate Cancer
|
5R21CA118362-02
|
$150,000
|
$37,500
|
Agoulnik, Alexander
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Molecular Mechanisms by which Rexinoids Prevent Breast Cancer
|
5R01CA078480-11
|
$341,085
|
$17,054
|
BROWN, POWEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-04
|
$280,899
|
$70,225
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$2,346
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$30,300
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mesenchymal Derived Growth Factors in Prostatic Cancer
|
5R01CA058093-15
|
$256,863
|
$64,216
|
ROWLEY, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Co-evolution of the Reactive Microenvironment in Prostate Cancer Progression
|
5U54CA126568-03
|
$529,800
|
$132,450
|
ROWLEY, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mechanism and Consequences of Telomere Dysfunction
|
1R01CA133249-01
|
$318,513
|
$79,628
|
Songyang, Zhou
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Enhancement of Dendritic Cells for Improved Immunotherapy
|
5R01CA120411-03
|
$258,529
|
$12,926
|
SPENCER, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Reversal of regulatory T cell function in prostate cancer
|
5R01CA121191-03
|
$258,529
|
$64,632
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targets of Vitamin D Receptor Action in Prostate
|
5R01CA107691-05
|
$292,538
|
$73,135
|
Weigel, Nancy
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The Role of Mitochondrial DNA Alterations in Cancer
|
5R01CA100023-05
|
$291,567
|
$72,892
|
Wong, Lee-Jun
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Characterization of prostatic stem cells and prostate cancer-initiating cells
|
7K99CA125937-02
|
$89,179
|
$22,295
|
Xin, Li
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$27,195
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Targeting AR-NCoR Interaction in Prostate Cancer
|
5R01CA111803-02
|
$323,000
|
$80,750
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
The Role of PTEN and the PI3K Pathway in Prostate Cancer
|
5P01CA089021-07
|
$2,026,408
|
$506,602
|
CANTLEY, LEWIS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Androgen Receptor Regulation by Phosphorylation
|
1K99CA135592-01
|
$97,295
|
$24,324
|
CHEN, SHAOYONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Choline Metabolism in Prostate Cancers: Response to Dietary Soy Phytochemicals
|
5R21CA130013-02
|
$170,000
|
$42,500
|
GASTON, SANDRA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Rigid Multivalent Chemical Platform for Targeted Diagnostics and Therapeutics
|
1F32CA132332-01A1
|
$51,278
|
$12,820
|
Nasr, Khaled
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
PTEN and ontogenesis and tumor suppression
|
2R01CA082328-11
|
$344,028
|
$22,362
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Control of Protein Translation in Cancer Pathogenesis
|
7U01CA084292-10
|
$697,531
|
$87,191
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Characterization of Prostate Cancer with 3T MR
|
5R01CA116465-03
|
$366,158
|
$91,540
|
ROFSKY, NEIL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Harvard/Michigan Prostate Cancer Biomarker Clinical Ctr
|
5U01CA113913-04
|
$826,363
|
$206,591
|
SANDA, MARTIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
The function of RhoBTB proteins
|
5R01CA113559-03
|
$293,000
|
$73,250
|
Soltoff, Stephen
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Parental metabolic status and offspring cancer risks
|
5R03CA130131-02
|
$85,000
|
$10,625
|
ZHOU, JIN-RONG
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Total relevant funding to Aging for this search: $162,224,132
|
